Related Experiment Video
Updated: May 22, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Dyslipidemia Management in Older Adults
Amrita Krishnamurthy1, Samuel M Kim2
1Department of Cardiology, Palo Alto Medical Foundation, Sutter Health, Dublin, CA, USA.
Clinics in Geriatric Medicine
|May 20, 2026
Summary
Older adults with or at high risk for cardiovascular disease benefit from lipid-lowering therapies like statins. Treatment should focus on functional status and comorbidities, not age alone, to prevent adverse cardiovascular outcomes.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Cardiovascular disease (CVD) is a primary cause of death in the US.
- Older adults frequently have dyslipidemia, a key CVD risk factor.
- Existing treatments effectively manage lipid levels in this demographic.
Purpose of the Study:
- To review the role of lipid-lowering therapies in older adults.
- To emphasize the importance of these treatments for CVD prevention in the elderly.
- To guide clinical decisions regarding lipid management in aging populations.
Main Methods:
- Review of numerous clinical trials on statins and nonstatin lipid-lowering drugs.
- Analysis of evidence for primary and secondary CVD prevention in older adults.
- Evaluation of factors influencing treatment de-escalation decisions.
Main Results:
- Statins and nonstatin therapies are safe and effective in older adults.
- Lipid-lowering treatments reduce major adverse cardiovascular outcomes.
- Age alone is not a valid reason to discontinue therapy.
Conclusions:
- Lipid-lowering therapies are crucial for older adults at risk for or with CVD.
- Treatment decisions should prioritize functional status and comorbidities over chronological age.
- Continued use of effective lipid management strategies is recommended for this population.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...